Global Pediatric Clinical Trials Market Research Report 2022

Report Format: PDF   |   Report ID: 5515704   |   Published Date: August 2022   |   Pages:  102  

Choose License
Market Analysis and Insights: Global Pediatric Clinical Trials Market
The global Pediatric Clinical Trials market size is projected to reach US$  million by 2028, from US$  million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Pre-Clinical Phase accounting for % of the Pediatric Clinical Trials global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While Neuropsychiatric Conditions segment is altered to an % CAGR throughout this forecast period.
China Pediatric Clinical Trials market size is valued at US$  million in 2021, while the North America and Europe Pediatric Clinical Trials are US$  million and US$  million, severally. The proportion of the North America is  % in 2021, while China and Europe are  % and respectively, and it is predicted that China proportion will reach  % in 2028, trailing a CAGR of  % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR  %,  %, and   % respectively for the next 6-year period. As for the Europe Pediatric Clinical Trials landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pediatric Clinical Trials market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pediatric Clinical Trials market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pediatric Clinical Trials market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pediatric Clinical Trials market.
Global Pediatric Clinical Trials Scope and Market Size
Pediatric Clinical Trials market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pediatric Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Pre-Clinical Phase
    Phase I
    Phase II
    Phase III
Segment by Application
    Neuropsychiatric Conditions
    Infectious Diseases
    Respiratory Diseases
    Cardiovascular Diseases
    Cancer
    Others
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    IQVIA Holdings, Inc.
    Parexel International
    CenterWatch
    Syneos Health
    Charles River Laboratories
    Covance Inc.
    ICON Plc.
    Pharmaceutical Product Development, LLC.
    Genentech (Roche)
    Pfizer
    Bristol-Myers Squibb
    GlaxoSmithKline
    Sanofi S.A.
    Novartis AG
    Johnson & Johnson
    Shire (Takeda)
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pediatric Clinical Trials Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Pre-Clinical Phase
        1.2.3 Phase I
        1.2.4 Phase II
        1.2.5 Phase III
    1.3 Market by Application
        1.3.1 Global Pediatric Clinical Trials Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Neuropsychiatric Conditions
        1.3.3 Infectious Diseases
        1.3.4 Respiratory Diseases
        1.3.5 Cardiovascular Diseases
        1.3.6 Cancer
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Pediatric Clinical Trials Market Perspective (2017-2028)
    2.2 Pediatric Clinical Trials Growth Trends by Region
        2.2.1 Pediatric Clinical Trials Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Pediatric Clinical Trials Historic Market Size by Region (2017-2022)
        2.2.3 Pediatric Clinical Trials Forecasted Market Size by Region (2023-2028)
    2.3 Pediatric Clinical Trials Market Dynamics
        2.3.1 Pediatric Clinical Trials Industry Trends
        2.3.2 Pediatric Clinical Trials Market Drivers
        2.3.3 Pediatric Clinical Trials Market Challenges
        2.3.4 Pediatric Clinical Trials Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Pediatric Clinical Trials Players by Revenue
        3.1.1 Global Top Pediatric Clinical Trials Players by Revenue (2017-2022)
        3.1.2 Global Pediatric Clinical Trials Revenue Market Share by Players (2017-2022)
    3.2 Global Pediatric Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Pediatric Clinical Trials Revenue
    3.4 Global Pediatric Clinical Trials Market Concentration Ratio
        3.4.1 Global Pediatric Clinical Trials Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pediatric Clinical Trials Revenue in 2021
    3.5 Pediatric Clinical Trials Key Players Head office and Area Served
    3.6 Key Players Pediatric Clinical Trials Product Solution and Service
    3.7 Date of Enter into Pediatric Clinical Trials Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Clinical Trials Breakdown Data by Type
    4.1 Global Pediatric Clinical Trials Historic Market Size by Type (2017-2022)
    4.2 Global Pediatric Clinical Trials Forecasted Market Size by Type (2023-2028)
5 Pediatric Clinical Trials Breakdown Data by Application
    5.1 Global Pediatric Clinical Trials Historic Market Size by Application (2017-2022)
    5.2 Global Pediatric Clinical Trials Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Pediatric Clinical Trials Market Size (2017-2028)
    6.2 North America Pediatric Clinical Trials Market Size by Country (2017-2022)
    6.3 North America Pediatric Clinical Trials Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Pediatric Clinical Trials Market Size (2017-2028)
    7.2 Europe Pediatric Clinical Trials Market Size by Country (2017-2022)
    7.3 Europe Pediatric Clinical Trials Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Pediatric Clinical Trials Market Size (2017-2028)
    8.2 Asia-Pacific Pediatric Clinical Trials Market Size by Country (2017-2022)
    8.3 Asia-Pacific Pediatric Clinical Trials Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Pediatric Clinical Trials Market Size (2017-2028)
    9.2 Latin America Pediatric Clinical Trials Market Size by Country (2017-2022)
    9.3 Latin America Pediatric Clinical Trials Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Pediatric Clinical Trials Market Size (2017-2028)
    10.2 Middle East & Africa Pediatric Clinical Trials Market Size by Country (2017-2022)
    10.3 Middle East & Africa Pediatric Clinical Trials Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 IQVIA Holdings, Inc.
        11.1.1 IQVIA Holdings, Inc. Company Detail
        11.1.2 IQVIA Holdings, Inc. Business Overview
        11.1.3 IQVIA Holdings, Inc. Pediatric Clinical Trials Introduction
        11.1.4 IQVIA Holdings, Inc. Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.1.5 IQVIA Holdings, Inc. Recent Development
    11.2 Parexel International
        11.2.1 Parexel International Company Detail
        11.2.2 Parexel International Business Overview
        11.2.3 Parexel International Pediatric Clinical Trials Introduction
        11.2.4 Parexel International Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.2.5 Parexel International Recent Development
    11.3 CenterWatch
        11.3.1 CenterWatch Company Detail
        11.3.2 CenterWatch Business Overview
        11.3.3 CenterWatch Pediatric Clinical Trials Introduction
        11.3.4 CenterWatch Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.3.5 CenterWatch Recent Development
    11.4 Syneos Health
        11.4.1 Syneos Health Company Detail
        11.4.2 Syneos Health Business Overview
        11.4.3 Syneos Health Pediatric Clinical Trials Introduction
        11.4.4 Syneos Health Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.4.5 Syneos Health Recent Development
    11.5 Charles River Laboratories
        11.5.1 Charles River Laboratories Company Detail
        11.5.2 Charles River Laboratories Business Overview
        11.5.3 Charles River Laboratories Pediatric Clinical Trials Introduction
        11.5.4 Charles River Laboratories Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.5.5 Charles River Laboratories Recent Development
    11.6 Covance Inc.
        11.6.1 Covance Inc. Company Detail
        11.6.2 Covance Inc. Business Overview
        11.6.3 Covance Inc. Pediatric Clinical Trials Introduction
        11.6.4 Covance Inc. Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.6.5 Covance Inc. Recent Development
    11.7 ICON Plc.
        11.7.1 ICON Plc. Company Detail
        11.7.2 ICON Plc. Business Overview
        11.7.3 ICON Plc. Pediatric Clinical Trials Introduction
        11.7.4 ICON Plc. Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.7.5 ICON Plc. Recent Development
    11.8 Pharmaceutical Product Development, LLC.
        11.8.1 Pharmaceutical Product Development, LLC. Company Detail
        11.8.2 Pharmaceutical Product Development, LLC. Business Overview
        11.8.3 Pharmaceutical Product Development, LLC. Pediatric Clinical Trials Introduction
        11.8.4 Pharmaceutical Product Development, LLC. Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.8.5 Pharmaceutical Product Development, LLC. Recent Development
    11.9 Genentech (Roche)
        11.9.1 Genentech (Roche) Company Detail
        11.9.2 Genentech (Roche) Business Overview
        11.9.3 Genentech (Roche) Pediatric Clinical Trials Introduction
        11.9.4 Genentech (Roche) Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.9.5 Genentech (Roche) Recent Development
    11.10 Pfizer
        11.10.1 Pfizer Company Detail
        11.10.2 Pfizer Business Overview
        11.10.3 Pfizer Pediatric Clinical Trials Introduction
        11.10.4 Pfizer Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.10.5 Pfizer Recent Development
    11.11 Bristol-Myers Squibb
        11.11.1 Bristol-Myers Squibb Company Detail
        11.11.2 Bristol-Myers Squibb Business Overview
        11.11.3 Bristol-Myers Squibb Pediatric Clinical Trials Introduction
        11.11.4 Bristol-Myers Squibb Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.11.5 Bristol-Myers Squibb Recent Development
    11.12 GlaxoSmithKline
        11.12.1 GlaxoSmithKline Company Detail
        11.12.2 GlaxoSmithKline Business Overview
        11.12.3 GlaxoSmithKline Pediatric Clinical Trials Introduction
        11.12.4 GlaxoSmithKline Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.12.5 GlaxoSmithKline Recent Development
    11.13 Sanofi S.A.
        11.13.1 Sanofi S.A. Company Detail
        11.13.2 Sanofi S.A. Business Overview
        11.13.3 Sanofi S.A. Pediatric Clinical Trials Introduction
        11.13.4 Sanofi S.A. Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.13.5 Sanofi S.A. Recent Development
    11.14 Novartis AG
        11.14.1 Novartis AG Company Detail
        11.14.2 Novartis AG Business Overview
        11.14.3 Novartis AG Pediatric Clinical Trials Introduction
        11.14.4 Novartis AG Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.14.5 Novartis AG Recent Development
    11.15 Johnson & Johnson
        11.15.1 Johnson & Johnson Company Detail
        11.15.2 Johnson & Johnson Business Overview
        11.15.3 Johnson & Johnson Pediatric Clinical Trials Introduction
        11.15.4 Johnson & Johnson Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.15.5 Johnson & Johnson Recent Development
    11.16 Shire (Takeda)
        11.16.1 Shire (Takeda) Company Detail
        11.16.2 Shire (Takeda) Business Overview
        11.16.3 Shire (Takeda) Pediatric Clinical Trials Introduction
        11.16.4 Shire (Takeda) Revenue in Pediatric Clinical Trials Business (2017-2022)
        11.16.5 Shire (Takeda) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Pediatric Clinical Trials Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Pre-Clinical Phase Table 3. Key Players of Phase I Table 4. Key Players of Phase II Table 5. Key Players of Phase III Table 6. Global Pediatric Clinical Trials Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Pediatric Clinical Trials Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Pediatric Clinical Trials Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Pediatric Clinical Trials Market Share by Region (2017-2022) Table 10. Global Pediatric Clinical Trials Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Pediatric Clinical Trials Market Share by Region (2023-2028) Table 12. Pediatric Clinical Trials Market Trends Table 13. Pediatric Clinical Trials Market Drivers Table 14. Pediatric Clinical Trials Market Challenges Table 15. Pediatric Clinical Trials Market Restraints Table 16. Global Pediatric Clinical Trials Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Pediatric Clinical Trials Market Share by Players (2017-2022) Table 18. Global Top Pediatric Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Clinical Trials as of 2021) Table 19. Ranking of Global Top Pediatric Clinical Trials Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Pediatric Clinical Trials Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Pediatric Clinical Trials Product Solution and Service Table 23. Date of Enter into Pediatric Clinical Trials Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Pediatric Clinical Trials Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Pediatric Clinical Trials Revenue Market Share by Type (2017-2022) Table 27. Global Pediatric Clinical Trials Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Pediatric Clinical Trials Revenue Market Share by Type (2023-2028) Table 29. Global Pediatric Clinical Trials Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Pediatric Clinical Trials Revenue Market Share by Application (2017-2022) Table 31. Global Pediatric Clinical Trials Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Pediatric Clinical Trials Revenue Market Share by Application (2023-2028) Table 33. North America Pediatric Clinical Trials Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Pediatric Clinical Trials Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Pediatric Clinical Trials Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Pediatric Clinical Trials Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Pediatric Clinical Trials Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Pediatric Clinical Trials Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Pediatric Clinical Trials Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Pediatric Clinical Trials Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Pediatric Clinical Trials Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Pediatric Clinical Trials Market Size by Country (2023-2028) & (US$ Million) Table 43. IQVIA Holdings, Inc. Company Detail Table 44. IQVIA Holdings, Inc. Business Overview Table 45. IQVIA Holdings, Inc. Pediatric Clinical Trials Product Table 46. IQVIA Holdings, Inc. Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 47. IQVIA Holdings, Inc. Recent Development Table 48. Parexel International Company Detail Table 49. Parexel International Business Overview Table 50. Parexel International Pediatric Clinical Trials Product Table 51. Parexel International Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 52. Parexel International Recent Development Table 53. CenterWatch Company Detail Table 54. CenterWatch Business Overview Table 55. CenterWatch Pediatric Clinical Trials Product Table 56. CenterWatch Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 57. CenterWatch Recent Development Table 58. Syneos Health Company Detail Table 59. Syneos Health Business Overview Table 60. Syneos Health Pediatric Clinical Trials Product Table 61. Syneos Health Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 62. Syneos Health Recent Development Table 63. Charles River Laboratories Company Detail Table 64. Charles River Laboratories Business Overview Table 65. Charles River Laboratories Pediatric Clinical Trials Product Table 66. Charles River Laboratories Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 67. Charles River Laboratories Recent Development Table 68. Covance Inc. Company Detail Table 69. Covance Inc. Business Overview Table 70. Covance Inc. Pediatric Clinical Trials Product Table 71. Covance Inc. Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 72. Covance Inc. Recent Development Table 73. ICON Plc. Company Detail Table 74. ICON Plc. Business Overview Table 75. ICON Plc. Pediatric Clinical Trials Product Table 76. ICON Plc. Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 77. ICON Plc. Recent Development Table 78. Pharmaceutical Product Development, LLC. Company Detail Table 79. Pharmaceutical Product Development, LLC. Business Overview Table 80. Pharmaceutical Product Development, LLC. Pediatric Clinical Trials Product Table 81. Pharmaceutical Product Development, LLC. Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 82. Pharmaceutical Product Development, LLC. Recent Development Table 83. Genentech (Roche) Company Detail Table 84. Genentech (Roche) Business Overview Table 85. Genentech (Roche) Pediatric Clinical Trials Product Table 86. Genentech (Roche) Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 87. Genentech (Roche) Recent Development Table 88. Pfizer Company Detail Table 89. Pfizer Business Overview Table 90. Pfizer Pediatric Clinical Trials Product Table 91. Pfizer Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 92. Pfizer Recent Development Table 93. Bristol-Myers Squibb Company Detail Table 94. Bristol-Myers Squibb Business Overview Table 95. Bristol-Myers Squibb Pediatric Clinical TrialsProduct Table 96. Bristol-Myers Squibb Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 97. Bristol-Myers Squibb Recent Development Table 98. GlaxoSmithKline Company Detail Table 99. GlaxoSmithKline Business Overview Table 100. GlaxoSmithKline Pediatric Clinical TrialsProduct Table 101. GlaxoSmithKline Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 102. GlaxoSmithKline Recent Development Table 103. Sanofi S.A. Company Detail Table 104. Sanofi S.A. Business Overview Table 105. Sanofi S.A. Pediatric Clinical TrialsProduct Table 106. Sanofi S.A. Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 107. Sanofi S.A. Recent Development Table 108. Novartis AG Company Detail Table 109. Novartis AG Business Overview Table 110. Novartis AG Pediatric Clinical TrialsProduct Table 111. Novartis AG Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 112. Novartis AG Recent Development Table 113. Johnson & Johnson Company Detail Table 114. Johnson & Johnson Business Overview Table 115. Johnson & Johnson Pediatric Clinical TrialsProduct Table 116. Johnson & Johnson Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 117. Johnson & Johnson Recent Development Table 118. Shire (Takeda) Company Detail Table 119. Shire (Takeda) Business Overview Table 120. Shire (Takeda) Pediatric Clinical TrialsProduct Table 121. Shire (Takeda) Revenue in Pediatric Clinical Trials Business (2017-2022) & (US$ Million) Table 122. Shire (Takeda) Recent Development Table 123. Research Programs/Design for This Report Table 124. Key Data Information from Secondary Sources Table 125. Key Data Information from Primary Sources List of Figures Figure 1. Global Pediatric Clinical Trials Market Share by Type: 2021 VS 2028 Figure 2. Pre-Clinical Phase Features Figure 3. Phase I Features Figure 4. Phase II Features Figure 5. Phase III Features Figure 6. Global Pediatric Clinical Trials Market Share by Application in 2021 & 2028 Figure 7. Neuropsychiatric Conditions Case Studies Figure 8. Infectious Diseases Case Studies Figure 9. Respiratory Diseases Case Studies Figure 10. Cardiovascular Diseases Case Studies Figure 11. Cancer Case Studies Figure 12. Others Case Studies Figure 13. Pediatric Clinical Trials Report Years Considered Figure 14. Global Pediatric Clinical Trials Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 15. Global Pediatric Clinical Trials Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 16. Global Pediatric Clinical Trials Market Share by Region: 2021 VS 2028 Figure 17. Global Pediatric Clinical Trials Market Share by Players in 2021 Figure 18. Global Top Pediatric Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Clinical Trials as of 2021) Figure 19. The Top 10 and 5 Players Market Share by Pediatric Clinical Trials Revenue in 2021 Figure 20. North America Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. North America Pediatric Clinical Trials Market Share by Country (2017-2028) Figure 22. United States Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Canada Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Europe Pediatric Clinical Trials Market Share by Country (2017-2028) Figure 26. Germany Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. France Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. U.K. Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Italy Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Russia Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Nordic Countries Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Pediatric Clinical Trials Market Share by Region (2017-2028) Figure 34. China Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Japan Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. South Korea Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Southeast Asia Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. India Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Australia Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Latin America Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Latin America Pediatric Clinical Trials Market Share by Country (2017-2028) Figure 42. Mexico Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Brazil Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Middle East & Africa Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Middle East & Africa Pediatric Clinical Trials Market Share by Country (2017-2028) Figure 46. Turkey Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Saudi Arabia Pediatric Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. IQVIA Holdings, Inc. Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 49. Parexel International Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 50. CenterWatch Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 51. Syneos Health Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 52. Charles River Laboratories Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 53. Covance Inc. Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 54. ICON Plc. Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 55. Pharmaceutical Product Development, LLC. Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 56. Genentech (Roche) Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 57. Pfizer Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 59. GlaxoSmithKline Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 60. Sanofi S.A. Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 61. Novartis AG Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 62. Johnson & Johnson Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 63. Shire (Takeda) Revenue Growth Rate in Pediatric Clinical Trials Business (2017-2022) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us